Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Guidelines for the welfare and use of animals in cancer research
2010 Standout
ESUR prostate MR guidelines 2012
2012 Standout
Expanding global access to radiotherapy
2015 Standout
Oral Administration of 3,3’-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice1–3
2009
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis
2012
Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer
2002
Epidemiology of prostate cancer
1997
Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer
2012
Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults
2009 Standout
Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance
2003
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?
2004
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Biosensor developments: application to prostate-specific antigen detection
2007
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
2007 Guideline for the Management of Ureteral Calculi
2007 Standout
Perioperative antibiotic prophylaxis in urology
2001
The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis
2018
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
2014 Standout
Management of impacted proximal ureteral stone: Extracorporeal shock wave lithotripsy versus ureteroscopy with holmium: YAG laser lithotripsy
2013
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
2006
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Gene expression correlates of clinical prostate cancer behavior
2002 Standout
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Nrf2–Keap1 defines a physiologically important stress response mechanism
2004 Standout
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review
2008
Cancer-related inflammation
2008 StandoutNature
Aberrant PSA glycosylation—a sweet predictor of prostate cancer
2013
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Defining the Need for Breast Cancer Radiotherapy in the General Population: a Criterion-based Benchmarking Approach
2007
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
2005
Transition Zone Prostate Cancers: Features, Detection, Localization, and Staging at Endorectal MR Imaging
2006
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
2005
ERA SPECIFIC BIOCHEMICAL RECURRENCE-FREE SURVIVAL FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
2001
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Dietary Antioxidants and Human Cancer
2004
A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
2004
Analysis of body fluids for forensic purposes: From laboratory testing to non-destructive rapid confirmatory identification at a crime scene
2009 Standout
The role of radiotherapy in cancer treatment
2005 Standout
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era
2002
A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji)
2011 Standout
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
2001
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Prosthetic Joint Infection
2014 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
Normal Central Zone of the Prostate and Central Zone Involvement by Prostate Cancer: Clinical and MR Imaging Implications
2012
Works of Sinan Sözen being referenced
Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells in vitro
2014
Microstaging of pT1 Transitional Cell Carcinoma of the Bladder
2002
CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population
2004
Antibiotic Prophylaxis for Transrectal Biopsy of the Prostate: A Prospective Randomized Study of the Prophylactic Use of Single Dose Oral Fluoroquinolone Versus Trimethoprim-Sulfamethoxazole
1999
Glutathione S-transferase M1 gene polymorphism in bladder cancer patients
2001
Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages
2005
Serum interleukin-18 and nitric oxide activity in bladder carcinoma.
2004
PSA Isoforms in Prostate Cancer Detection
2006
Pneumatic lithotripsy for large ureteral stones: is it the first line treatment?
2007
HISTOLOGICAL AND CLINICAL FINDINGS IN 896 CONSECUTIVE PROSTATES TREATED ONLY WITH RADICAL RETROPUBIC PROSTATECTOMY: EPIDEMIOLOGIC SIGNIFICANCE OF ANNUAL CHANGES
1998
Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.
2004